DOJ Blocks Criminal Charges Against Walmart in Opioid Crisis
A recent ProPublica investigative report calls into question the Trump Administration’s commitment to ending the opioid crisis, criminally charging those responsible, and ensuring that protections are in place to prevent another crisis. Even as President Trump held television news conferences vowing to take a hard stance in combatting the opioid crisis and prosecute pharmaceutical companies […]
Risperdal Case Reinstated After Janssen Appeal Denied
The Pennsylvania Supreme Court declined to hear Janssen Pharmacuetical’s request for an appeal of a lower courts decision to reinstate the lawsuit of a Texas man who took Risperdal as a child. The Pennsylvania Superior Court’s decision to allow Tommy Moroni’s suit against Janssen, a subsidiary of Johnson & Johnson, to go back to trial will stand. July 2019, the Pennsylvania […]
Pharma Execs Admits to Deceptive Marketing of Opioids
In a rare admission to PBS Frontline & the Finical Times, a pharmaceutical executive acknowledged that he knowingly orchestrated an illegal scheme to boost sales of a powerful opiate painkiller believing there would be no consequences for him personally. Alec Burlakoff, Insys’ former head of sales received a 26-month sentence for charges related his role in the pharmaceutical company which […]
Plaintiff’s Counsel Vows to Have $8B Risperdal Verdict Reinstated
Philadelphia Court of Common Pleas Judge Kenneth Powell reduced an October 2019 $8 billion punitive damages verdict against J&J to $6.8 million. A jury had awarded the figure over allegations that J&J’s drug Risperdal caused the plaintiff to grow breasts as a young boy. The $6.8 million reduced verdict is 10 times the jury verdict […]
State and Local Lawmakers Goals Conflict in Opioid Litigation
Plaintiffs’ in the multi-district litigation, which consisting of more than 2,500 cities and counties, suing opioid manufacturers and distributors for their role in the opioid crisis find they have conflicting goals with state lawmakers in the ongoing opioid litigation. State attorneys general are adamant on taking drug manufacturers and distributors to trial in hopes of winning a […]
Positive Developments in Risperdal Litigation in August
Several positive developments this month for young men injured from taking the Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The drug’s side effects included gynecomastia, the growth of female-like breast in young boys. $2.5M Jury Verdict Stands The Supreme Court of Pennsylvania has declined to hear an appeal of […]
Opioid Drugmakers May Be Liable Under Consumer Protection Laws
Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and sales of opioid painkillers resulting in a nationwide epidemic. The suit, a first of its kind, brings claims under Pennsylvania’s Unfair Trade Practices and Consumer Protection Law. The UTPCPL bans […]
Sheller on Thom Hartman Radio Show
From The Ring of Fire: Why Is Big Pharma Increasing Your Medicine Prices? By Thom Hartmann – July 17, 2019 The US pays more for medical drugs that in any country in the world. Health in the US is all about making a profit and drug prices have increased dramatically since Trump become president. Drug […]
New Trial for Risperdal Injury Previously Tossed
In another win for plaintiffs injured by Risperdal, a Pennsylvania appellate court reversed a trial courts decision to grant the defendants motion for nonsuit, mid-trial. This decision will send the case back to the Pennsylvania Courts of Common Pleas for retrial. In the 2016 case of T.M. vs Janssen Pharmaceuticals, the trial judge decided mid-trial […]
Oklahoma Sues J&J Over Opioid Crisis
Purdue Pharma is named the main defendant in multiple city, state and local lawsuits against the pharmaceutical companies that played a part in the current opioid crisis. The suits claim the drug maker’s aggressive marketing of its opioid painkiller OxyContin began the crisis more than two decades ago. News media has covered the crisis extensively, including John Oliver […]
